News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

SUBSCRIBE

SUBSCRIBE

News
Insights
Jobs
Career Advice
Companies
Hotbeds
More

Search Query

Search Results

Looking for jobs? Search jobs

1,867 Results

Type

Article (214)
Company Profile (1)
Press Release (1652)

Section

Business (675)
Career Advice (1)
Deals (124)
Drug Delivery (7)
Drug Development (104)
FDA (16)
Job Trends (27)
News (911)
Policy (96)

Tag

Date

Last 7 days (3)
Last 30 days (11)
Last 365 days (129)
2025 (27)
2024 (128)
2023 (113)
2022 (217)
2021 (205)
2020 (159)
2019 (117)
2018 (135)
2017 (118)
2016 (97)
2015 (117)
2014 (65)
2013 (60)
2012 (43)
2011 (38)
2010 (48)

Location

Africa (2)
Asia (930)
Australia (13)
California (9)
Canada (1)
China (38)
Europe (142)
Florida (1)
India (2)
Japan (1)
Maryland (1)
Massachusetts (6)
New Jersey (5)
North Carolina (1)
Northern California (1)
Ohio (2)
Pennsylvania (2)
South America (1)
Southern California (4)
Texas (1)
Utah (1)
Washington D.C. (3)

Filters

Type

Article (214)
Company Profile (1)
Press Release (1652)

Section

Business (675)
Career Advice (1)
Deals (124)
Drug Delivery (7)
Drug Development (104)
FDA (16)
Job Trends (27)
News (911)
Policy (96)

Tag

Date

Last 7 days (3)
Last 30 days (11)
Last 365 days (129)
2025 (27)
2024 (128)
2023 (113)
2022 (217)
2021 (205)
2020 (159)
2019 (117)
2018 (135)
2017 (118)
2016 (97)
2015 (117)
2014 (65)
2013 (60)
2012 (43)
2011 (38)
2010 (48)

Location

Africa (2)
Asia (930)
Australia (13)
California (9)
Canada (1)
China (38)
Europe (142)
Florida (1)
India (2)
Japan (1)
Maryland (1)
Massachusetts (6)
New Jersey (5)
North Carolina (1)
Northern California (1)
Ohio (2)
Pennsylvania (2)
South America (1)
Southern California (4)
Texas (1)
Utah (1)
Washington D.C. (3)

1,867 Results for "wuxi apptec".

Sort By

Press Releases

NAMSA Completes Acquisition of WuXi AppTec US Medical Device Testing Business

March 4, 2025
·
2 min read
BIOSECURE Act

WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms

With the BIOSECURE Act likely to be voted on in Congress this year, WuXi AppTec’s U.S. revenue dropped 1.2% in the first half of 2024 while the Chinese company increased its lobbying efforts.

July 29, 2024
·
2 min read
·
Tyler Patchen
Press Releases

WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)

January 13, 2025
·
2 min read
Press Releases

WuXi AppTec Revenue and Profit Achieved Steady QoQ Growth in 2024, Meeting Full-year Guidance; Q4 Revenue and Profit Both Reached Record Highs

March 18, 2025
·
23 min read
BIOSECURE Act

WuXi Mulls Sale of Some US, European Operations: FT

The Financial Times reported Thursday that WuXi AppTec is looking to sell its cell and gene therapy manufacturing unit, with facilities in Philadelphia, while WuXi Biologics wants to offload some of its production sites in Europe.

October 3, 2024
·
2 min read
·
Tristan Manalac
BIOSECURE Act

WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow

WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as the companies await the Senate’s review of the BIOSECURE Act that threatens to cut them off from U.S. biopharma.

October 8, 2024
·
5 min read
·
Ben Hargreaves
Press Releases

NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research

January 17, 2025
·
3 min read
Policy

BIO Separates from China’s WuXi AppTec Amid National Security Concerns

In a change of position as congressional scrutiny of WuXi AppTec grows, the Biotechnology Innovation Organization announced it is taking steps to separate from the China-based biotech.

March 14, 2024
·
3 min read
·
Tristan Manalac
Policy

WuXi AppTec Shared Client IP with Beijing, Say US Intelligence Officials: Reuters

U.S. intelligence officials have informed senators that China-based biotech WuXi AppTec transferred an American client’s intellectual property to the Chinese government without consent, reports Reuters.

March 29, 2024
·
2 min read
·
Tristan Manalac
Business

WuXi AppTec Achieved First Quarter 2024 Target Despite External Challenges, Maintaining Stable Operations

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and life sciences industry, announced its financial results for the first quarter ending March 31, 2024.

April 29, 2024
·
18 min read

1 of 187

BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.

Explore
About
More

© 1985 - 2025 BioSpace.com. All rights reserved.

twitter
instagram
facebook
linkedin